HELLENiQ ENERGY Holdings SA Stock Price, News & Analysis
Company Description
HELLENiQ ENERGY Holdings SA (OTC Link: HLPMF) is a publicly traded oil & gas refining & marketing company in the Energy sector. The company has a market capitalization of $3.4B.
HLPMF stock has gained 26.1% over the past year.
This page provides a comprehensive overview of HLPMF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
HELLENiQ ENERGY Holdings SA (HLPMF) stock. Over the past 12 months, the stock has gained 26.1%. At a market capitalization of $3.4B, HLPMF is classified as a mid-cap stock with approximately 305.6M shares outstanding.
Latest News
HELLENiQ ENERGY Holdings SA has 2 recent news articles, with the latest published 2 days ago. Key topics include earnings. View all HLPMF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in HELLENiQ ENERGY Holdings SA (HLPMF) currently stands at 100 shares, down 86.5% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 84.6%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for HELLENiQ ENERGY Holdings SA (HLPMF) currently stands at 1000.0 days, up 22371.7% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 4.2 to 1000.0 days.
HLPMF Company Profile & Sector Positioning
HELLENiQ ENERGY Holdings SA (HLPMF) operates in the Oil & Gas Refining & Marketing industry within the broader Energy sector and is listed on the OTC Link.